GaryA.PeltzMD
Rheumatology • San Francisco, CAProfessor, Anesthesia, Stanford University Medical Center
Are you Dr. Peltz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave Plaza Level
San Francisco, CA 94143Phone+1 415-353-2497Fax+1 415-353-2530
Summary
- Dr. Gary Peltz, MD is a rheumatologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with Stanford Health Care and VA Palo Alto Heath Care.
Education & Training
Stanford University School of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 1985 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- The role of 5-HT modulation in opioid withdrawal and neonatal opioid withdrawal syndrome: mechanisms and potential serotonergic targets.Kevin Lam, Gary Peltz, Walter K Kraft
Expert Opinion on Investigational Drugs. 2025-02-08 - Bayesian Population Pharmacokinetic Modeling of Ondansetron for Neonatal Opioid Withdrawal Syndrome.Kevin Lam, John T Mondick, Gary Peltz, Manhong Wu, Walter K Kraft
Clinical and Translational Science. 2025-02-01 - A Murine Database of Structural Variants Enables the Genetic Architecture of a Spontaneous Murine Lymphoma to be Characterized.Wenlong Ren, Zhuoqing Fang, Egor Dolzhenko, Christopher T Saunders, Zhuanfen Cheng
Biorxiv. 2025-01-14
Press Mentions
Stanford Trial Finds a Common Anti-Nausea Drug Could Reduce Severity of Opioid Withdrawal in NewbornsOctober 14th, 2022- Drug May Be First Non-Opioid Treatment for Infant WithdrawalOctober 12th, 2022
Pelzman's Picks: An Uptick in Legionnaire'sMay 29th, 2018- Join now to see all
Grant Support
- AI-based genetic discovery for hearing lossSTANFORD UNIVERSITY2023–2028
- Enabling AI-based Mouse Genetic DiscoverySTANFORD UNIVERSITY2023–2027
- Enabling AI-based Mouse Genetic DiscoverySTANFORD UNIVERSITY2023–2027
- Enabling AI-based Mouse Genetic DiscoverySTANFORD UNIVERSITY2023–2027
- A Model for Human Liver FibrosisSTANFORD UNIVERSITY2022–2025
- Human Pharmacogenetics And Human Liver RegenerationNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Pharmacogenetic Analysis In Mice (II)National Institute Of General Medical Sciences2007
- Pharmacogenetic Analysis In MiceNational Institute Of General Medical Sciences2004–2006
- Novel Snp-Allele Genotyping MethodNational Human Genome Research Institute2000–2002
